An open label, randomized, parallel, phase II trial to evaluate the efficacy and safety of cremophor-free, polymeric micelle formulation of paclitaxel compared to paclitaxel in subjects with ovarian cancer.
Yong-Man Kim
No relevant relationships to disclose
Shin-Wha Lee
No relevant relationships to disclose
Chi Heum Cho
No relevant relationships to disclose
Soo-Young Hur
No relevant relationships to disclose
Byoung-Gie Kim
No relevant relationships to disclose
Jae Hoon Kim
No relevant relationships to disclose
Seung Cheol Kim
No relevant relationships to disclose
Seok-Mo Kim
No relevant relationships to disclose
Young-Tae Kim
No relevant relationships to disclose
Hee Sug Ryu
No relevant relationships to disclose
Soon-Beom Kang
No relevant relationships to disclose